Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2009 | 04-2009 | 01-2009 | 10-2008 | 07-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 445,000 | 2,070,000 | 1,967,000 | 1,270,000 | 723,000 |
| Depreciation Amortization | 231,000 | 853,000 | 636,000 | 428,000 | 211,000 |
| Income taxes - deferred | 68,000 | -171,000 | 63,000 | 43,000 | -3,000 |
| Accounts receivable | 37,000 | 108,000 | 252,000 | 270,000 | 42,000 |
| Other Working Capital | -135,000 | 259,000 | 212,000 | -31,000 | 12,000 |
| Other Operating Activity | -25,000 | 759,000 | -375,000 | -360,000 | -185,000 |
| Operating Cash Flow | $621,000 | $3,878,000 | $2,755,000 | $1,620,000 | $800,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -296,000 | -115,000 | -64,000 | -556,000 | -545,000 |
| PPE Investments | -150,000 | -498,000 | -378,000 | -263,000 | -127,000 |
| Net Acquisitions | N/A | -1,624,000 | -381,000 | -29,000 | -29,000 |
| Purchase Sale Intangibles | N/A | -165,000 | -152,000 | -135,000 | N/A |
| Other Investing Activity | -83,000 | -503,000 | -422,000 | -140,000 | 21,000 |
| Investing Cash Flow | $-529,000 | $-2,740,000 | $-1,245,000 | $-988,000 | $-680,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 148,000 | -633,000 | 41,000 | -124,000 | 481,000 |
| Debt Issued | N/A | 1,250,000 | N/A | N/A | N/A |
| Debt Repayment | -6,000 | -300,000 | -316,000 | -300,000 | -300,000 |
| Common Stock Issued | 36,000 | 416,000 | 393,000 | 367,000 | 198,000 |
| Common Stock Repurchased | -344,000 | -759,000 | -726,000 | -639,000 | -175,000 |
| Dividend Paid | -228,000 | -843,000 | -632,000 | -421,000 | -211,000 |
| Other Financing Activity | 0 | 24,000 | 23,000 | 26,000 | 11,000 |
| Financing Cash Flow | $-394,000 | $-845,000 | $-1,217,000 | $-1,091,000 | $4,000 |
| Exchange Rate Effect | 53,000 | -82,000 | -70,000 | -60,000 | -14,000 |
| Beginning Cash Position | 1,271,000 | 1,060,000 | 1,060,000 | 1,060,000 | 1,060,000 |
| End Cash Position | 1,022,000 | 1,271,000 | 1,283,000 | 541,000 | 1,170,000 |
| Net Cash Flow | $-249,000 | $211,000 | $223,000 | $-519,000 | $110,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 621,000 | 3,878,000 | 2,755,000 | 1,620,000 | 800,000 |
| Capital Expenditure | -150,000 | -498,000 | -378,000 | -263,000 | -127,000 |
| Free Cash Flow | 471,000 | 3,380,000 | 2,377,000 | 1,357,000 | 673,000 |